"Designing Growth Strategies is in our DNA"

Merkel Cell Carcinoma Therapeutics Market Size, Share and Global Trend By Therapy (Chemotherapy, Immunotherapy, Combination Therapy, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Geography Forecast till 2030

Region : Global | Report ID: FBI100615 | Status : Ongoing



Merkel Cell Carcinoma (MCC), also known as neuroendocrine carcinoma, is a rare (about forty times less likely to occur than the relatively less rare & better known malignant melanoma) and highly aggressive form of skin cancer. Merkel cell carcinoma is caused by the Merkel cell polyomavirus (MCPyV or MCV) and generally first appears as a single, painless lump on the skin exposed to the sun. The exact cause of Merkel cell carcinoma is unclear, but individuals at risk of being diagnosed include those with excessive exposure to sunlight & UV rays, weakened immune system, and history of other skin cancers of advanced age.

Merkel cell carcinoma is classified into five stages, ranging from Stage 0 (carcinoma in situ) to Stage IV. Merkel cell carcinoma carries the risk of metastasizing, which leads to the spreading of cancer to the other parts of the body, and the metastasized cancer is often difficult to cure and often proves to be fatal. The treatment for Merkel cell carcinoma includes surgical procedures, radiation therapy, and chemotherapy.

To gain extensive insights into the market, Request for Customization

The global Merkel cell carcinoma therapeutics market is anticipated to grow, owing to a number of factors such as increasing prevalence of Merkel cell carcinoma, improving health reimbursement, increased exposure to UV rays due to global warming and pollution, higher prevalence of immunosuppression resulting in increased occurrences of the cancer and increased research & development of therapeutics.

According to the American Cancer Society, skin cancer is the most common form of cancer in the U.S., but due to the very rare nature of Merkel cell carcinoma, about 2,000 cases of it are diagnosed in the U.S. each year. The American Cancer Society also estimates that 4 out of the 5 diagnosed will be above 70 years of age and its nearly twice as likely in males than in females. These trends, combined with the other factors, are expected to positively drive the market growth.

The factors limiting the growth of the global Merkel cell carcinoma therapeutics market are the lack of diagnosis or misdiagnosis, high cost of treatment and its associated side effects, and the inconclusive and recurrent nature of the treatment.

Key Players Covered

Some of the major companies that are present in the global Merkel cell carcinoma therapeutics market are Amgen Inc., Merck & Co., Pfizer Inc., BeiGene, OncoSec Medical Incorporated, Bristol-Myers Squibb Company, and Immune Design.




By Therapy

·      Chemotherapy

·      Immunotherapy

·      Combination Therapy

·      Others

By Distribution Channel

·      Hospital Pharmacy

·      Retail Pharmacy

·      Online Pharmacy

By Geography

·      North America (USA and Canada)

·      Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)

·      Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)

·      Latin America (Brazil, Mexico and Rest of Latin America)

·      Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)


Based on the therapy, the chemotherapy segment is projected to dominate the global Merkel cell carcinoma therapeutics market in the forecast period owing to the improving health reimbursement, increased research, and improved distribution networks. Furthermore, the preference for chemotherapy drugs for the treatment of cancer by physicians is expected to favor the expansion of chemotherapy segment in the global Merkel cell carcinoma therapeutics market.

Key Insights

  • Prevalence of Merkel cell carcinoma for key countries
  • Pipeline analysis
  • Patent snapshot
  • Regulatory scenario for key countries
  • Reimbursement Scenario for key countries
  • Recent industry developments such as partnerships, mergers, and acquisitions

Regional Analysis

North America is projected to dominate the global Merkel cell carcinoma therapeutics market in the forecast period owing to the increasing demand for oncology drugs, high R&D spending, and government research grants. The growth in Merkel cell carcinoma therapeutics market in Europe is likely to propel due to strategic collaborations and active government support. Asia Pacific is the fastest emerging market due to, rising prevalence of Merkel cell carcinoma and increased focus by improving distribution network in this region.

Key Industry Developments   

  • In January 2019, Nantkwest, Inc. announced the launch of phase 2 clinical study on triple combination immunological therapy for the treatment of Merkel cell carcinoma.
  • In December 2018, Merck & Co., Inc. received FDA approval for KEYTRUDA for treating paediatric and adult patients with metastatic or recurrent locally advanced Merkel cell carcinoma.
  • In March 2017, Merck KGaA and Pfizer Inc. received FDA approval for BAVENCIO, an intravenous injection for treatment of Merkel cell carcinoma.

  • Ongoing
  • 2022
  • 2019-2021


  • $4850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

Siemens Healthineers

Client Testimonials

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- UGlobal hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.